{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Normal+Subjects&page=13", "query": { "condition": "Normal Subjects", "page": 13 }, "page_size": 10 }, "pagination": { "page": 13, "page_size": 10, "total_count": 2506, "total_pages": 251, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Normal+Subjects&page=14&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Normal+Subjects&page=12&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T05:31:41.508Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04163263", "title": "Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Moderate to Severe Acne Vulgaris" ], "interventions": [ { "name": "BOS-356", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boston Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 66, "start_date": "2019-11-04", "completion_date": "2020-11-11", "has_results": false, "last_update_posted_date": "2020-11-27", "last_synced_at": "2026-10-24T05:31:41.508Z", "location_count": 6, "location_summary": "Fremont, California • Sanford, Florida • High Point, North Carolina + 3 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "Sanford", "state": "Florida" }, { "city": "High Point", "state": "North Carolina" }, { "city": "Austin", "state": "Texas" }, { "city": "College Station", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04163263" }, { "nct_id": "NCT03717506", "title": "Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "GDC 268 Lotion", "type": "DRUG" }, { "name": "Clindamycin Phosphate Lotion 1%", "type": "DRUG" }, { "name": "GDC Vehicle Lotion", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Balmoral Medical company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Years to 40 Years" }, "enrollment_count": 1236, "start_date": "2018-10-10", "completion_date": "2020-04-16", "has_results": true, "last_update_posted_date": "2021-05-04", "last_synced_at": "2026-10-24T05:31:41.508Z", "location_count": 34, "location_summary": "Fort Smith, Arkansas • Rogers, Arkansas • Fountain Valley, California + 31 more", "locations": [ { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03717506" }, { "nct_id": "NCT02889796", "title": "Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo to match filgotinib", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Placebo to match adalimumab", "type": "DRUG" }, { "name": "MTX", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1759, "start_date": "2016-08-30", "completion_date": "2019-06-20", "has_results": true, "last_update_posted_date": "2021-06-09", "last_synced_at": "2026-10-24T05:31:41.508Z", "location_count": 48, "location_summary": "Huntsville, Alabama • Phoenix, Arizona • Tucson, Arizona + 45 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Hemet", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02889796" }, { "nct_id": "NCT00999141", "title": "Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Face-lift", "Facial Rhytidectomy" ], "interventions": [ { "name": "FS VH S/D 4 s-apr", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Baxter Healthcare Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 75, "start_date": "2009-09", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2012-10-08", "last_synced_at": "2026-10-24T05:31:41.508Z", "location_count": 6, "location_summary": "Beverly Hills, California • Atlanta, Georgia • Evans, Georgia + 3 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Evans", "state": "Georgia" }, { "city": "Hewlett", "state": "New York" }, { "city": "Chattanooga", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00999141" }, { "nct_id": "NCT05785741", "title": "A Study of DB-1310 in Advanced/Metastatic Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced Solid Tumor" ], "interventions": [ { "name": "DB-1310", "type": "DRUG" }, { "name": "Trastuzumab", "type": "DRUG" }, { "name": "Osimertinib", "type": "DRUG" }, { "name": "capecitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "DualityBio Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2023-08-17", "completion_date": "2028-04-30", "has_results": false, "last_update_posted_date": "2026-04-06", "last_synced_at": "2026-10-24T05:31:41.508Z", "location_count": 15, "location_summary": "Sacramento, California • Santa Monica, California • Coral Gables, Florida + 12 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Margate", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05785741" }, { "nct_id": "NCT00319254", "title": "Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Neoplasms", "Neoplasm Metastasis" ], "interventions": [ { "name": "SKI-606 (Bosutinib)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 75, "start_date": "2006-05", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2013-01-31", "last_synced_at": "2026-10-24T05:31:41.508Z", "location_count": 4, "location_summary": "Duarte, California • Santa Monica, California • Tampa, Florida + 1 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00319254" }, { "nct_id": "NCT05139602", "title": "A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hidradenitis Suppurativa" ], "interventions": [ { "name": "Lutikizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2021-12-28", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-02-13", "last_synced_at": "2026-10-24T05:31:41.508Z", "location_count": 25, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Hot Springs, Arkansas + 20 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05139602" }, { "nct_id": "NCT02272595", "title": "Rational Therapeutics Based on Matched Tumor and Normal Tissue", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Advanced Cancers" ], "interventions": [ { "name": "Treatment Based on Genetic Mutation", "type": "OTHER" }, { "name": "Treatment Based on No Genetic Mutation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2014-11-04", "completion_date": "2022-01-11", "has_results": false, "last_update_posted_date": "2022-02-15", "last_synced_at": "2026-10-24T05:31:41.508Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02272595" }, { "nct_id": "NCT00964561", "title": "Ph1 Study of Valortim and Ciprofloxacin in Humans", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Anthrax" ], "interventions": [ { "name": "Ciprofloxacin and Valortim", "type": "DRUG" }, { "name": "Placebo Antibiotic and Valortim", "type": "DRUG" }, { "name": "Placebo Antibiotic and Placebo Valortim", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "PharmAthene, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "18 Years to 59 Years" }, "enrollment_count": 26, "start_date": "2009-08", "completion_date": "2010-07", "has_results": false, "last_update_posted_date": "2010-08-10", "last_synced_at": "2026-10-24T05:31:41.508Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00964561" }, { "nct_id": "NCT01114841", "title": "A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Tazarotene Foam", "type": "DRUG" }, { "name": "Vehicle Foam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stiefel, a GSK Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 254, "start_date": "2010-03-31", "completion_date": "2010-06-26", "has_results": false, "last_update_posted_date": "2017-06-14", "last_synced_at": "2026-10-24T05:31:41.508Z", "location_count": 1, "location_summary": "Scottsdale, Arizona", "locations": [ { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01114841" } ] }